SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Hester Biosciences - Quaterly Results

10 Aug 2022 Evaluate
Net sales declined -13.63%  to  Rs. 505.28 million from Rs. 585.05 millions.A big decline of -59.10% was reported for the quarter ended June 2022 to Rs. 50.05  millions from Rs. 122.37 millions of corresponding previous quarter.The company reported a degrowth in operating Profit to 104.32 millions from 191.81 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202206 202106 % Var 202206 202106 % Var 202203 202103 % Var
Sales 505.28 585.05 -13.63 505.28 585.05 -13.63 2193.51 2084.77 5.22
Other Income 12.34 10.32 19.57 12.34 10.32 19.57 46.57 16.48 182.58
PBIDT 104.32 191.81 -45.61 104.32 191.81 -45.61 652.26 736.41 -11.43
Interest 12.69 3.67 245.78 12.69 3.67 245.78 24.68 39.47 -37.47
PBDT 91.63 188.14 -51.30 91.63 188.14 -51.30 627.58 644.16 -2.57
Depreciation 23.93 22.98 4.13 23.93 22.98 4.13 95.02 96.33 -1.36
PBT 67.70 165.16 -59.01 67.70 165.16 -59.01 532.56 547.83 -2.79
TAX 17.65 42.79 -58.75 17.65 42.79 -58.75 137.39 148.82 -7.68
Deferred Tax -2.52 -7.03 -64.15 -2.52 -7.03 -64.15 -5.14 -14.83 -65.34
PAT 50.05 122.37 -59.10 50.05 122.37 -59.10 395.17 399.01 -0.96
Equity 85.07 85.07 0.00 85.07 85.07 0.00 85.07 85.07 0.00
PBIDTM(%) 20.65 32.79 -37.03 20.65 32.79 -37.03 29.74 35.32 -15.82

Hester Biosciences Share Price

1649.65 11.45 (0.70%)
08-May-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1847.30
Dr. Reddys Lab 1293.25
Cipla 1347.70
Zydus Lifesciences 938.90
Lupin 2377.90
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×